TEVA: מקדם החזר מותאם קצב צמיחה Teva Pharmaceuticals

סמל ולוגו של המותג tevapharm.com (TEVA)

Steady growth in branded drug sales has provided Teva Pharmaceutical Industries (TEVA) with high liquidity. The GURU.Markets service features a PEG ratio chart, where the latest value is recorded as 2.22. While quotes depend on fierce pricing competition in the generics segment, competent management is successfully reducing debt and introducing new biosimilars, effectively managing anti-crisis processes.

TEVA יחס מחיר לרווח לקצב צמיחה Teva Pharmaceutical Industries Ltd. (04.07.2022 - 17.11.2026)

פילוחים אנליטיים של חברת Teva Pharmaceutical Industries Limited (TEVA)

ניתוח פונדמנטלי של החברה:Teva Pharmaceutical Industries Ltd. (TEVA)
מוצרים מיוצרים של Teva Pharmaceuticals

The PEG ratio determines investment attractiveness by comparing a company's market value to its net income growth rate, where a value below one indicates an undervalued asset. By analyzing historical PEG levels, an investor can gauge the scaling efficiency of Teva Pharmaceutical Industries (TEVA), whose dominance in the generics segment and control over active pharmaceutical ingredient production ensure low costs and sustainable profit growth.